TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.

We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to sudden death. The clinical trial will investigate whether rapamycin can reduce the life-threatening heart remodelling associated with SAS. It is hoped our novel therapy […]

A great catch up with our colleagues in the US.

Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US where they got to connect and catch up with thought leaders in veterinary medicine. We were grateful to be represented by Stuart at the Comparative Gastroenterology Society at GutSea giving us the opportunity to connect with our colleagues […]

CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.

A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of TriviumVet has been announced Entrepreneur of the Year at the Waterford Business Awards, organised by Waterford Chamber and supported by Dungarvan & West Waterford […]

TriviumVet attend Animal Health Summit London 2022

Our CEO Louise Grubb and COO Tom Brennan attended a very interesting Animal Health conference in London last week. A very informative event engaging all key participants in the value chain to address the full scope of how animal health impacts pet owners, veterinarians and farmers. It involved excellent speakers and it was brilliant to […]

TriviumVet represented at the VMX Conference presented by North American Veterinary Community

It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community (NAVC) in Orlando last week where they got to touch base and connect with veterinary professionals from around the world.  

TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.

Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing authorisation applications and provided information on the benefits from early dialogue and continuous interaction with EMA during development of innovative veterinary medicines.

TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – RapaVet® – to treat dilated cardiomyopathy in dogs.

TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second most-common acquired cardiac disease in dogs. In its early stage, called the preclinical stage, dogs are apparently healthy to their owners, but beneath the surface, DCM causes a […]

IHS Markit feature: TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps

TriviumVet_gearing_up_for_pet_pipeline_launches_to_bridge_therapeutic_gaps In case you missed it the first time around you can read the FULL ARTICLE here where IHS Markit’s Sian Lazell caught up with TriviumVet CEO Louise Grubb Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is now […]